2
Executive Summary
Commences public offering of 3 mil. shares at $ 13.875, the company said Aug. 8. The offering reflects an increase from the 2.5 mil. share offering originally proposed. Tucker Anthony is underwriting the offering. Net proceeds will be used to pay off debt, conduct clinical trials, to purchase equipment, and for "protection of patent right." North American Vaccine recently sued Lederle for patient infringement.